But it's not just about the number on the scale
Demand may continue to increase as more GLP-1 agonists are approved for other conditions, such as preventing heart attacks or strokes in adults with cardiovascular disease
Then the dose escalations kick in, and weeks 6 through 8 become what trial participants called the survival phase. During these weeks, nausea rates peak at 28%
For an accurate assessment of your specific case value, contact TruLaw using the chat on this page to receive a personalized case evaluation
(PubMed) Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS
Under the bridge program, Part D plans are required to use standardized prior authorization criteria, but the process still involves documentation, submission, and sometimes appeals